Background: Cadmium is a widespread environmental and occupational pollutant that accumulates in human body with a biological half-life exceeding 10 years. Cadmium exposure has been demonstrated to increase rates of cardiovascular diseases. Whether occupational cadmium exposure is associated with the increase in the prevalence of dyslipidemia and hence contributes to the risk of cardiovascular diseases is still equivocal. To test the hypothesis that exposure to cadmium is related to the prevalence of dyslipidemia, we examined the associations between blood cadmium concentration and the prevalence of dyslipidemia in workers occupationally exposed to cadmium in China. Methods: A cross-sectional survey on demographic data, blood cadmium level and lipid profile in cadmium exposed workers from seven cadmium smelting factories in central and southwestern China was conducted. We measured blood cadmium concentration and lipid components of 1489 cadmium exposed workers. The prevalence of dyslipidemia was compared across blood cadmium quartiles. Associations between the blood cadmium concentrations and the prevalence of dyslipidemia were assessed using confounder adjusted linear and logistic regressions. Results: The blood cadmium concentration was 3.61±0.84μg/L ( mean ±SD). The prevalence of dyslipidemia in this occupational population was 66.3%. Mean blood cadmium concentration of workers with dyslipedemia was significantly higher than that of workers without dyslipidemia (p <0.01). The prevalence of dyslipidemia increased dose-dependently with elevations in blood cadmium concentrations (p for trend <0.001). Elevated levels of blood cadmium were associated with BMI, education attainment, income, smoking status and duration of exposure (all p <0.01). Furthermore, the profile of blood lipid was obviously changed in this occupational population.
Cadmium Exposure is Associated with the Prevalence of Dyslipidemia

Introduction
Environmental exposure is an important but underappreciated risk factor that disturbs lipid metabolism in humans [1] . Cadmium, a highly toxic heavy metal, is widely distributed in the environment and as a pollutant emanating from industrial and agricultural sources into ambient air and soil. Environmental cadmium levels have risen steadily due to continued worldwide anthropogenic mobilization and increased cadmium production and consumption in industries [2, 3] . Cadmium and its compounds are commonly used in electroplating, alloy production, and the production of nickel-cadmium batteries. Human exposure to cadmium could pose serious health challenges, especially among occupationally exposed workers. In China, cadmium pollution in the environment by the rapid industrialization during past decades has become a major public concern due to the diverse toxic effects and potential human health risks [4] .
Atmospheric contamination by industrial emissions from cadmium-related industry and cigarette smoking are the major sources of cadmium exposure to humans. In the occupational population, cadmium is inhaled in the workplace either as a dust or a fume [5] . The general public is exposed to cadmium from contaminated air, foods and drinking water and cigarette smoking [6] . Most absorbed cadmium is distributed to kidney, bone, liver and other organs of the body through the blood stream regardless its exposure route and the blood cadmium concentration, hence, is generally accepted as a reliable biomarker of assessing exposure levels [7] . Besides being a carcinogen [8] , cadmium exposure is associated with kidney diseases [9] , osteoporosis and bone fracture [10, 11] , atherosclerosis and cardiovascular diseases [12] . Cadmium is associated with increased mortality from cardiovascular disease even at low-level exposure in general population. Epidemiological studies on association of environmental exposure to cadmium and prevalence of cardiovascular disease indicated that cardiovascular disease was 36% more likely in highest exposure category compared with the lowest. The hazard ratios were 1.43 for cardiovascular mortality, and 1.34 for coronary heart disease mortality [13, 14] . Although the detailed mechanism remains to be elucidated, several animal studies have indicated that cadmium exposure may disturb lipid metabolism, cause dyslipidemia and result in atherosclerosis [15, 16] . Dyslipidemia is a status of blood lipid abnormalities and well recognized as one of the strongest traditional risk factors for the development of cardiovascular diseases [17] . Nevertheless, no known studies have examined the association between the occupational exposure to cadmium and prevalence of dylipidemia. In this investigation, we had two primary goals: (1) to investigate the prevalence of dyslipidemia and its associative factors in occupational cadmium exposed population; and (2) to reveal the profile of blood lipid abnormalities in cadmium exposed workers.
Materials and Methods
Study population
This study was conducted in Hunan Province, Guangxi Zhuang Autonomous Region and Chongqing Municipality City, China. These three areas located in central and southwestern China are the traditional sites of cadmium mining, milling and smelting industries in China. A total of 1763 workers from 7 cadmium smelting factories in these three areas were enrolled in the project of Health Survey on Cadmium Exposed Workers (HSCEW) in the year of 2013. The HSCEW is a governmental project jointly granted by Chongqing Science & Technology Commission and Chongqing Health & Family Planning Commission. The aim of HSCEW is to inspect current status of working environment in workplace of traditional cadmium production industries and assess the health risk of cadmium exposed workers so as to further control occupational hazards and improve health services in cadmium related industries. The study was approved by the Ethics Committee of Third Military Medical University. A total of 1763 workers occupationally exposed to cadmium and employed two or more years in these 7 smelting factories were recruited in the study population,. Signed informed consent was obtained from all participant workers. Among 1763 workers enrolled, 141 who did not provide sufficient blood samples for biochemical analysis or had missing responses on the questionnaires were excluded from the analysis. In addition, 29 pregnant workers, 43 workers with medication for dyslipidemia or cardiovascular diseases, 28 workers with medication for chronic hepatic diseases, and 33 workers with anti-diabetic medication were also excluded. Therefore, the final analysis included a total of 1489 workers.
Data and blood collection
A face-to-face interview was conducted by trained health workers with standard questionnaires from April to November 2013 to obtain data on demographics, health status, and lifestyle in the seven cadmium smelting factories. These included questions on age, sex, education attainment, income, smoking habits and alcohol use. Height and weight were measured with the participants wearing light clothing and no shoes. Body mass index (BMI) was then calculated as weight (in kilograms) divided by the square of height (in meters). Blood samples for cadmium measurement and lipid analysis were collected in the same time period.
Laboratory measurements
Fasting peripheral venous blood samples were collected by EDTA-contained tubes and centrifuged to separated plasma and then stored at -80℃ until analysis. Plasma triglyceride (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) were measured using an automatic biochemical analyzer (Hitachi 7080, Tokyo, Japan) with regents purchased from Wako Pure Chemical Industries (Osaka, Japan). Blood cadmium was quantified by inductively coupled plasmamass spectrometry (ICP-MS, Thermo Fisher X-series 2, Houston, TX, USA) using the same method as described previously [18] . All the containers or tubes were pre-cleaned by overnight soaking in ultrapure grade 2% HNO 2 solution. Whole blood samples were treated with 0.1% Triton and 1% HNO 2 as well as 1% ammonia solution. Before cadmium concentration analyses, the digests were diluted to a final volume of 50 ml using Mili-Q water (Millipore, Milford, MA, USA) and filtered through 0.45 µm filters. The detection limits were 0.05 µg/L. Quality control was performed (1 out of 20 samples) and inter-and intra-assay coefficients of variation were <10% and <5% respectively.
Variable Definitions
Hypertriglyceridermia (high TG) was defined according to a TG>1.7 mmol/L, hypercholesterolemia (high TC) was defined based on a TC>5.2 mmol/L, a high LDL-C level was defined based on a LDL-C >2.6 mmol/L, a low HDL-C level was defined based on a HDL-C <0.9 mmol/L (male) or a HDL-C <1.1 mmol/L (female) [19] . Above cutoff values were used in this study to define blood lipid status. Dyslipidemia was defined as the presence of any one of the following four factors: high TC levels, high TG levels, high LDL-C levels, or low HDL-C levels [20] .
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Statistic Analysis
Analysis of covariance for continuous variables and multivariate logistic regression analysis for categorical variables were applied for the comparison across blood cadmium quartiles. A logistic regression model was used to test odds ratios (ORs) and confidence intervals (CIs) of dyslipidemia and its pattern for each blood cadmium quartile compared with the lowest quartile, with adjustment for age, sex, BMI, education level, income, smoking status, alcohol use, and duration of exposure. The presence of a linear trend was evaluated by defined a linear contrast in each linear and logistic regression model. Stratified analyses were performed according to the categorical variables. Likelihood ratio tests were conducted to examine interactions. These statistical methods were used in the previously reported epidemiological studies [21] [22] [23] . All statistical analyses were performed with SAS (Version 9.3, SAS Institute Inc, USA).
Results
Characteristics of study population
This study population included 1489 Cd exposed workers with the mean blood cadmium concentration of 4.82±1.64 μg/L (mean ±SD). Characteristics of these Cd exposed workers with and without dyslipidemia are presented Table 1 . The prevalence of dyslipidemia in this study population was 66.3%. The mean blood Cd concentration of workers with dyslipidemia was 5.79 ±1.16 μg/L and significantly higher than 2.46±0.73 μg/L in workers without dyslipidemia (p<0.01). Workers with dyslipidemia were more likely to be current smokers and have higher BMI, lower educational attainment, lower monthly income, and longer duration of exposure. The percentage of the lowest education attainment and lowest monthly income in workers with dyslipidemia was significantly higher than that of workers without dyslipidemia (p<0.01). 64.3% of workers with dyslipidemia were current smokers. 65 .8%. of workers with duration of exposure more than 10 years had dyslipidemia.
The basic characteristics and blood lipid components of the study workers sorted by quartiles of blood cadmium concentration are shown in Table 2 . Blood cadmium concentration was positively correlated with BMI, education level, smoking status and duration of exposure (all p for trend <0.01). Nevertheless, increased blood cadmium concentration was not correlated with age, sex and alcohol use (all p for trend >0.05). With cadmium concentration increased, mean blood TC elevated from 4.14 mmol/L (blood cadmium quartile 1) to 8. 
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Prevalence of dyslipidemia and profile of blood lipid components Figure 1 shows the prevalence of dyslipidemia among 1489 workers occupationally exposed to cadmium. The prevalence of hypercholesterolemia (high TC), hypertriglyceridemia (high TG), low HDL-C and high LDL-C were 40.4%, 39.4%, 36.9, 29.4% in this occupational Cd exposed population respectively. In addition, a total of 37.2% of Cd exposed workers had mixed dyslipidemia, defined as presence of at least two lipid abnormalities. As shown in Table  3 , prevalence of high TC, high TG, low HDL-C and high LDL-C were all elevated according to quartiles of blood cadmium concentration (all p for trend <0.001). Prevalence of two types of mixed dyslipidemia (i.e. high TG + low HDL-C; high TG + low HDL-C + high LDL-C) also increased with elevation of blood cadmium concentration (p for trend <0.01, 0.001 respectively). However, the trend in prevalence of the other two types of mixed dyslipidemia (i.e. high TG + high LDL-C; low HDL-C + high LDL-C) were not significantly related to elevated blood cadmium concentration (all p for trend >0.05).
Multivariable analysis for cadmium exposure and dyslipidemia
Multivariable analyses showed the associations between blood cadmium concentrations and prevalence of lipid abnormalities after adjustment for sex, age, BMI, monthly income, education attainment, smoking status, alcohol use, and duration of exposure. Table 4 shows the results of adjusted odds ratios (ORs) for the association of blood lipid profile with blood cadmium concentrations. The ORs (95% CIs) for dyslipidemia from the lowest to the highest blood cadmium quartiles were 1.26 (1.14-1.83), 1.52 (1.16-2.34) and 1.96 (1.38-2.96) respectively (referencing to 1.00) (p for trend <0.001) after adjusting for age and sex (model 1). The cadmium-dyslipidemia association was not materially changed (p for trend <0.001) by further controlling for education attainment, monthly income, and lifestyle covariates (model 2), as well as additionally adjusted for and duration of exposure (model 3) (all p for trend <0.001). The ORs (95% CIs) for high TC, high TG, low HDL-C and high LDL-C were 1.73(1.13-2.34), 1.69(1.09-2.28), 1.77(1.14-2.44), and 1.66(1.03-2.27) respectively in the highest blood cadmium quartiles (referencing to 1.00 in the lowest blood cadmium quartile). There showed a significant dose-dependent association between elevated blood cadmium concentration and lipid component abnormalities (all p for trend <0.001). The association between blood cadmium concentration and lipid component abnormalities was also not materially changed after further adjusting for age and sex (model 1), education attainment, monthly income and lifestyle covariates (model 2), as well as duration of exposure (model 3) (all p for trend <0.001).
Discussion
Cadmium is a redundant occupational and environmental contaminant and has been generally accepted to cause a number of diseases. Workers of a large variety of occupations, especially those are involved in manufacture of alloy and battery, and nonferrous metal smelting and refining, are exposed to high level of cadmium through inhalation of dust and fumes, and incidental ingestion of dust from contaminated hands, cigarettes or foods. The rapid economic growth in China during the past three decades has led to the increased consumption of cadmium related products and the expansion of occupational cadmium exposed population [24] . Cadmium exposure of general population in China and other Asian countries is generally higher than in Europe and the United States, because of the large number of cadmium-polluting industries and high intake of rice and vegetables grown locally in cadmium-contaminated soil [25, 26] . Marked dose-dependent association between urinary cadmium levels and prevalence of renal dysfunction was observed in the population of cadmium polluted areas of southern China [27] [28] [29] . Prevention of environmental and occupational cadmium exposure is still a major public concern in China. It is imperative to control cadmium exposure of occupational population in cadmium related industries though Chinese effort in industrial health management has greatly improved the environment at workplace and reduced hazardous exposure in recent years.
Several epidemiological studies revealed that cadmium exposure in general population significantly increases the mortality from all causes and serves as an independent risk factor for cardiovascular diseases [13] . Dyslipidemia is a major independent modifiable risk factor for cardiovascular diseases. The prevalence of dyslipidemia varies widely according to the ethnic, socioeconomic, and cultural characteristics of distinct population groups. The prevalence of dyslipidemia is high and increasing in most developed countries as well as in many developing countries as a result of the westernization of diet, obesity, reduced physical activity and other adverse lifestyle changes [30] . However there is a paucity of information on the association between the occupational and environmental exposure to toxic heavy metals and the prevalence of dyslipidemia. Especially no known study was conducted to assess the relationship between the occupational exposure to cadmium and the prevalence of lipid abnormalities. The study in the population with occupational exposure is of particular value in elucidating adverse health effects, as not only is exposure likely to have been greater in the occupational than in the general environment, but also is markedly more effective following inhalation of cadmium oxide fume and cadmium-containing dusts than after the intake of cadmium in food or water [31] .
To the best of our knowledge, this is the first occupational population based study to assess the association between blood cadmium concentration and the prevalence of dyslipidemia. The elevated blood cadmium burden was associated with an increased risk of having dyslipidemia in cadmium exposed workers. This association was independent of traditional dyslipidemia risk factors including lifestyle, BMI and so on. Although both blood and urinary cadmium levels are used to estimate cadmium body burden in epidemiological studies, blood cadmium concentration is considered the most valid biomarker of recent exposure and internal dose. It may also serve as a biomarker for long-term accumulation after long-term low-level exposure [32] . Since blood cadmium level closely correlated with urinary cadmium level, the association found in present study would not be markedly altered by the use of urinary cadmium level as a biomarker of cadmium body burden. Previous prospective studies investigating the association of blood cadmium concentrations with cardiovascular outcomes have mostly supported an association with cardiovascular risk [33, 34] , but the evidence without study conducted in occupational population has been disputable.
In our present cross-sectional study conducted in occupational Cd exposed population, elevated levels of blood cadmium were associated with not only elevated prevalence of dyslipidemia, but also increased prevalence of high TC, high TG, high LDL-C and low HDL-C in Cd exposed population. These results suggest that long-term high level exposure to cadmium could disturb lipid metabolism and alter normal blood lipid profile in occupational population. Although there has been no study designed to investigate the association between the cadmium exposure and the prevalence of dyslipidemia, results from previous studies revealed that higher blood cadmium and other heavy metal (mercury, lead) levels in Korean adults and in Iran adolescents were related with the changes blood lipid components. In these studies conducted in general population, no significant relationship between blood Cd level and the risk of high LDL-C or high TG was observed [35, 36] . The discrepancy of the changes in lipid profile between general population and occupational population may result from differences in source, intensity and duration of Cd exposure. For the general population, dietary uptake and cigarette smoking are the major sources and the exposure is low level, whereas for the occupational population, inhalation of cadmium-containing fumes and dusts is the main source and the exposure level is relatively high.
The underlying pathogenic mechanism of dyslipidemia induced by cadmium exposure is not fully understood yet. Many experimental studies were aimed to elucidate the effects of cadmium on lipid metabolism. Low-level cadmium exposure via drinking water induced low HDL-C and high TG in mice and rats in a dose-dependent manner [37, 38] . Chronic exposure to cadmium may disturb lipid metabolism and result in dyslipidemia via direct inhibition of numerous enzymes related to lipid metabolism. Furthermore, Cadmium depletes glutathione and protein-bound sulfhydryl groups, resulting in the enhanced production od reactive oxygen species, which induces increased lipid peroxidation [30] . After adjustment for potential confounders including age, sex, BMI, lifestyle factors and so on, data from our study provided the first epidemiological evidence that occupational exposure to cadmium could elevate the prevalence dyslipidemia and alter normal blood lipid profile in humans. Given that the disturbance of lipid metabolism is a crucial risk factor for many diseases including many cardiovascular conditions, monitoring the changes of blood lipid profile could be of great importance in medical surveillance for health risk in occupation population. It is important to further elucidate the mechanisms of cadmium induced dyslipidemia and evaluate the effects of cadmium on lipid metabolism in an occupational population with long-term high level exposure.
Our present study conducted in relatively large-scale occupational population has revealed the association of occupational cadmium exposure and prevalence of dyslipidemia. The prevalence of dyslipidemia in this occupational population exposed to cadmium was as high as 73.2% and much higher than 53% in U.S. general population [39] . Since the causal relation between dyslipidemia and atherosclerosis and other cardiovascular diseases was well established and early intervention of dyslipidemia has been proven to be effective way of reducing the rate of death from cardiovascular diseases [40] , results of our present study call for the early awareness and intervention of dyslipidemia among the workers with longterm occupational exposure to cadmium. Data from this study indicate that there is an acute need for monitoring, diagnosing and treating dyslipidemia in health services provided for workers occupationally exposed cadmium.
Though comprehensive information regarding potential confounders were carefully analyzed and controlled in the statistical analyses, our study has certain limitations. First, due to the cross-sectional design, a causal relationship between cadmium exposure and dyslipidemia cannot be established. Second, a single measurement of blood cadmium concentration may not reflect long-term exposure though some studies suggested that under steady state conditions a single measurement of blood or urinary cadmium level seems to be acceptable as it can reflect body cadmium burden of long-term exposure. Third, the results of this study may have been confounded by unmeasured covariates, such as preexisting diseases. Finally, genetic factors influencing lipid metabolism may be confounded and result in a bias in our present study [41] . Therefore, further prospective study with distinct cardiovascular outcomes in this occupational cadmium exposed population will be performed and other trace elements like Fe, Zn, Cu, Mn, Se in the blood will be determined to assess the possible correlation with dyslipidemia in the future. Except for blood cadmium level as an early maker of cadmium exposure, some novel biomarkers in blood to assess cadmium toxicity at population level are needed in the future epidemiological study.
Conclusion
Our present study is the first to assess the associations between blood cadmium levels and the prevalence of dyslipidemia in a relatively large occupational population. The results indicate that occupational exposure to cadmium significantly and dose-dependently increases the prevalence of dyslipidemia and obviously alters blood lipid profile in humans. From the perspective of public health, the early awareness and intervention of dyslipidemia in workers occupationally exposed to cadmium is acutely needed. The change of blood lipid profile could serve as an indicator of adverse health effects of cadmium exposure in occupational population. The further study with prospective designs and distinct cardiovascular outcomes is warranted to elucidate the mechanisms underlying the relation between cadmium exposure and dyslipidemia in humans.
